Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study

被引:26
作者
Kania, Aleksander [1 ]
Krenke, Rafal [2 ]
Kuziemski, Krzysztof [3 ]
Czajkowska-Malinowska, Malgorzata [4 ]
Celejewska-Wojcik, Natalia [1 ]
Kuznar-Kaminska, Barbara [5 ]
Farnik, Malgorzata [6 ]
Bokiej, Juliusz [7 ]
Miszczuk, Marta [2 ]
Damps-Konstanska, Iwona [3 ]
Grabicki, Marcin [5 ]
Trzaska-Sobczak, Marzena [6 ]
Sladek, Krzysztof [1 ]
Batura-Gabryel, Halina [5 ]
Barczyk, Adam [6 ]
机构
[1] Jagiellonian Univ, Med Coll, Fac Med, Dept Pulmonol,Chair Internal Med 2, Skawinska 8, PL-31066 Krakow, Poland
[2] Med Univ Warsaw, Dept Internal Med Pulm Dis & Allergy, Warsaw, Poland
[3] Med Univ Gdansk, Dept Allergol & Pneumonol, Gdansk, Poland
[4] Reg Ctr Pulmonol, Dept Lung Dis & Resp Failure, Bydgoszcz, Poland
[5] Poznan Univ Med Sci, Dept Pulmonol Allergol & Resp Oncol, Poznan, Poland
[6] Med Univ Silesia, Sch Med Katowice, Dept Pneumol, Katowice, Poland
[7] Reg Hosp Ctr Jelenia Gora, Dept Lung Dis, Jelenia Gora, Poland
关键词
chronic obstructive pulmonary disease; asthma-COPD overlap syndrome; phenotypes; OBSTRUCTIVE PULMONARY-DISEASE; OVERLAP SYNDROME ACOS; CLINICAL PHENOTYPES; GUIDELINES; ASTHMA; COMBINATION; POPULATION; SOCIETY; BIOMASS; HEALTH;
D O I
10.2147/COPD.S154716
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: This study aimed to examine the distribution of predefined phenotypes, demographic data, clinical outcomes, and treatment of patients who were included in the Polish cohort of the Phenotypes of COPD in Central and Eastern Europe (POPE) study. Patients and methods: This was a sub-analysis of the data from the Polish cohort of the POPE study, an international, multicenter, observational cross-sectional survey of COPD patients in Central and Eastern European countries. The study included patients aged.40 years, with a confirmed diagnosis of COPD, and absence of exacerbation for at least 4 weeks before study inclusion. A total of seven Polish centers participated in the study. Results: Among the 430 Polish COPD patients enrolled in the study, 61.6% were non-exacerbators (NON-AE), 25.3% were frequent exacerbators with chronic bronchitis (AE CB), 7.9% were frequent exacerbators without chronic bronchitis (AE NON-CB), and 5.1% met the definition of asthma-COPD overlap syndrome (ACOS). There were statistically significant differences among these phenotypes in terms of symptom load, lung function, comorbidities, and treatment. Patients with the AE CB phenotype were most symptomatic with worse lung function, and more frequently reported anxiety and depression. Patients with the ACOS phenotype were significantly younger and were diagnosed with COPD earlier than those with other COPD phenotypes; those with the ACOS phenotype were also more often atopic and obese. Conclusion: There is significant heterogeneity among COPD patients in the Polish population in terms of phenotype and clinical outcome. The non-exacerbator phenotype is observed most frequently in Poland, while the frequent exacerbator with chronic bronchitis phenotype is the most symptomatic.
引用
收藏
页码:1613 / 1621
页数:9
相关论文
共 35 条
[1]   Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis [J].
Alshabanat, A. ;
Zafari, Z. ;
Albanyan, O. ;
Dairi, M. ;
FitzGerald, J. M. .
PLOS ONE, 2015, 10 (09)
[2]  
[Anonymous], 2014, GLOB STRAT ASTHM MAN
[3]  
Barrecheguren M, 2015, COPD RES PRACT, V1, P8, DOI 10.1186/s40749-015-0012-z
[4]   The asthma - chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges [J].
Barrecheguren, Miriam ;
Esquinas, Cristina ;
Miravitlles, Marc .
CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (01) :74-79
[5]   Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[6]   Asthma-COPD overlap syndrome (ACOS) vs "pure' COPD: a distinct phenotype? [J].
Caillaud, D. ;
Chanez, P. ;
Escamilla, R. ;
Burgel, P-R. ;
Court-Fortune, I. ;
Nesme-Meyer, P. ;
Deslee, G. ;
Perez, T. ;
Paillasseur, J-L. ;
Pinet, C. ;
Jebrak, G. ;
Roche, N. .
ALLERGY, 2017, 72 (01) :137-145
[7]  
Chen Bingheng, 2008, Environmental Health and Preventive Medicine, V13, P94, DOI 10.1007/s12199-007-0018-5
[8]   Distributionand Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort [J].
Cosio, Borja G. ;
Soriano, Joan B. ;
Luis Lopez-Campos, Jose ;
Calle, Myriam ;
Jose Soler, Juan ;
Pablo de-Torres, Juan ;
Maria Marin, Jose ;
Martinez, Cristina ;
de Lucas, Pilar ;
Mir, Isabel ;
Peces-Barba, German ;
Feu-Collado, Nuria ;
Solanes, Ingrid ;
Alfageme, Inmaculada .
PLOS ONE, 2016, 11 (09)
[9]  
European Environment Agency, 52014 EUR ENV AG
[10]   Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease [J].
Gershon, Andrea S. ;
Campitelli, Michael A. ;
Croxford, Ruth ;
Stanbrook, Matthew B. ;
To, Teresa ;
Upshur, Ross ;
Stephenson, Anne L. ;
Stukel, Therese A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (11) :1114-1121